Introduction: After the diagnosis of neoplasm of the middle and distal rectum, patients are often submitted to oncological treatment by neoadjuvant therapy. At the end of this treatment, those patients who show complete clinical response can choose, together with their physician, to adopt the watch-and-w...
Objectives: To evaluate the complete response (CR) rate and surgeries performed in patients with rectal adenocarcinoma who underwent neoadjuvant therapy (NT) at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo and at Hospital São Paulo, in Ribeirão Preto, from January 2007 ...
Background: Many publications describe the advantages of the creation of ghost ileostomy (GI) to prevent the need for formal covering ileostomy in more than 80% of carcinoma rectum patients. However, none of the papers describes exactly how to ultimately remove the GI in these 80% of patients in whom it ...
Background: It is important to detect novel biomarkers responsible for the progression and spread of colorectal cancer (CRC) to better evaluate the prognosis of the patients, provide better management, and foster the development of therapeutic targets. In humans, pyrroline-5-carboxylate reductase 2 (PYCR...
Introduction: Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods: A cohort prospecti...
Resumen Durante las últimas décadas los avances en técnicas quirúrgicas, radioterapia y quimioterapia han logrado de forma significativa aumentar la sobrevida y disminuir la recidiva local en el cáncer de recto evitando una colostomía definitiva; sin embargo, este trascendental progreso médico no ...
ABSTRACT BACKGROUND: Hospital-based studies recently have shown increases in colorectal cancer survival, and better survival for women, young people, and patients diagnosed at an early disease stage. OBJECTIVE: To describe the overall survival and analyze the prognostic factors of patients treated fo...
Antineoplásicos/uso terapéutico,
Brasil/epidemiología,
Neoplasias del Colon/mortalidad,
Neoplasias del Colon/patología,
Neoplasias del Colon/terapia,
Neoplasias Colorrectales/mortalidad,
Neoplasias Colorrectales/patología,
Neoplasias Colorrectales/terapia,
Persona de Mediana Edad,
Estadificación de Neoplasias,
Pronóstico,
Neoplasias del Recto/mortalidad,
Neoplasias del Recto/patología,
Neoplasias del Recto/terapia,
Sistema de Registros,
Estudios Retrospectivos,
Índice de Severidad de la Enfermedad,
Sobrevida,
Análisis de Supervivencia,
Tasa de Supervivencia
Análisis Costo-Beneficio,
Costos de la Atención en Salud,
Neoplasias del Recto/economía,
Neoplasias del Recto/terapia,
Espera Vigilante/economía,
Quimioradioterapia,
América Latina,
Proctectomía/economía,
Calidad de Vida,
Neoplasias del Recto/diagnóstico,
Resultado del Tratamiento
Abstract Here we describe an infrequent case of gastrointestinal stromal tumor of the rectum in a 57 year-old man with spindle cell neoplasm probably gastrointestinal stromal tumor and CT scan showed tumor from the anterior rectal wall and offered abdominoperineal resection for the same. The patient was ...
Motiva esta presentación el hecho que desde el Relato “Opciones terapéuticas del Cáncer de Recto Inferior” en el año 2008 han pasado 10 años y por supuesto aparecieron algunos progresos y cambios. Se conoce gran heterogeneidad genética debido que puede desarrollarse por diferentes vías. Nuevos...
